Facebook Pixel Code
About Sickkids
About SickKids

Molly Malone, PhD

University of Toronto
Assistant Professor

Associate Member
Paediatrics, School of Graduate Studies

Phone: 416-813-6333
Fax: 416-813-7437
Email: molly.malone@sickkids.ca

Brief Biography

Dr. Malone completed her undergraduate training in psychology at the University of Toronto. She obtained her MA in Applied Child Psychology from the University of Guelph and her PhD in Special Education and Applied Psychology from the University of Toronto. She is a member of the College of Psychologists of Ontario. Dr. Malone is on staff in the Child Development Centre HSC. At the University of Toronto she holds appointments as Assistant Professor, Department of Paediatrics, Extramural Instructor in Human Development & Applied Psychology and Associate Member in the School of Graduate Studies. She is a Project Director in the Research Institute, HSC.

Areas of Specialty:

Attention Deficit Disorder/Attention Deficit Hyperactivity Disorder

Academic Background

PhD in Special Education
University of Toronto, Ontario Institute for Studies in Education, 1983-09-01 - 1986-09-01

Research Interests

Furthering the understanding of the cognitive effects of medication treatment for children with Attention Deficit Hyperactivity Disorder (ADHD). Approaches to studying medication effects have included hemispheric processing and neurophysiological measures. Dr. Malone is also currently interested in identifying genetic factors that may contribute to the etiology of ADHD in collaboration with a research team at HSC led by Dr. Cathy Barr.

Research Activities

October 1997 - September 2002 Medical Research Council of Canada
Co-investigator with C. Barr: "Genetic factors in ADHD"

January 2000 - December 2001 HSC Foundation
Co-investigator with J Wiener: "Self-concept in ADHD Children"

April 2001-March 2003 Canadian Institutes of Health Research
Co-investigator with R. Schachar: “ADHD: Cognitive Deficit and Syndrome Definition”

July 2002- Sept 2005 Social Sciences and Humanities Research Council of Canada (SSHRC)
Co-investigator with J. Wiener: “Teacher’s Understanding and Perceptions of ADHD”

October 2002 – Sept 2005 Canadian Institutes of Health Research (CIHR)
Co-Investigator with C. Barr: “Investigation of Genetic Factors in Attention Deficit Hyperactivity Disorder”

Future Research Interests

Evaluation of affective changes in children with ADHD treated with stimulant medication, possibly through the use of videotapes of facial expression, vocal intonation and gestures. In addition, Dr. Malone would like to investigate the effects of other types of medication for children with ADHD.


Quist JF, Barr CL, Schachar R, Roberts W, Malone MA, Tannock R, Basile VS, Beitchman J, Kennedy JL. The serotonin 5-HT1B receptor gene and attention deficit hyperactivity disorder (ADHD). Molecular Psychiatry 2003; 8:98-102.

Malone MA, Rosenfield, JD, Roberts W. Methylphenidate effects on the grapho-motor artwork of children with attention deficit hyperactivity disorder. Canadian Art Therapy Association Journal, 2002, 15:7-13.

Wigg K, Zai G, Schachar R, Tannock R, Roberts W, Malone MA, Kennedy JL, Barr CL. Attention deficit hyperactivity disorder and the gene for dopamine beta hydroxylase. American Journal of Psychiatry, 2002, 159:1046-1048.

Barr CL, Shulman R, Wigg KG, Schachar R, Tannock R, Roberts W, Malone MA, Kennedy JL. Linkage study of polymorphisms in the gene for myelin oligodendrocyte glycoprotein located on chromosome 6p and attention deficit hyperactivity disorder. American Journal of Medical Genetics (Neuropsychiatric Genetics), 2001, 105:250-254.

Barr CL, Wigg K, Zai G, Roberts W, Malone MA, Schachar R, Tannock R, Kennedy JL. Attention deficit hyperactivity disorder and the adrenergic receptors 1C and  2C. Molecular Psychiatry, 2001, 6: 334-337.

Barr CL, Feng Y, Wigg K, Roberts W, Malone M, Schachar R, Tannock R, Gruen JR, Goei V, Kennedy JL. Identification of polymorphisms in the GABAB receptor gene and linkage study of attention deficit hyperactivity disorder. Gene Function and Disease, 2000, 5-6:1-8.